Document Detail

Coarctation of the Aorta Stent Trial (COAST): Study design and rationale.
MedLine Citation:
PMID:  22795276     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Coarctation of the aorta (CoA) accounts for 4% to 5% of congenital cardiac abnormalities. Stent therapy has become an accepted alternative to surgery for older children and adults, although there are no balloon-expandable stents approved by the Food and Drug Administration for use in the aorta. The Cheatham-Platinum (CP) stent was designed for CoA therapy and is widely used outside the United States. We have designed the first prospective trial of stent therapy for CoA to serve as the pivotal trial for Food and Drug Administration approval of the CP stent.
METHODS: The COAST study is a prospective, multicenter, single-arm clinical study. The population includes patients with native or recurrent CoA. Four primary outcome variables were defined. For each variable, the stent will be compared to performance guidelines derived from surgical experience. The first efficacy outcome is reduction in arm-leg systolic blood pressure gradient, and the second is reduction in hospital length of stay. Safety outcomes include the following: the occurrence of any serious or somewhat serious adverse event attributed to the stent or implantation procedure and the occurrence of postprocedure paradoxical hypertension. A total of 105 patients treated with the CP stent will be enrolled.
DISCUSSION: To ascertain the effectiveness and safety of an interventional device, randomized controlled trials have been offered as the criterion standard. However, these trials are not well suited to study rare conditions such as CoA, especially once the therapy in question has received acceptance within the medical community. New clinical trial and statistical approaches are needed to evaluate such therapies. The COAST study is an example of this kind of innovative trial design.
Richard E Ringel; Kimberlee Gauvreau; Heidi Moses; Kathy J Jenkins
Related Documents :
8409046 - Use of a regional wall motion score to enhance risk stratification of patients receivin...
9214786 - Development of a microcontroller-based automatic control system for the electrohydrauli...
17251876 - Retrospective analysis of the prognostic value of electroencephalography patterns obtai...
2703616 - Long-term outcome with the automatic implantable cardioverter-defibrillator.
23326186 - Comparison of different intraocular pressure measurement techniques in normal eyes, pos...
21676056 - A randomized controlled trial of capnography in the correction of simulated endotrachea...
Publication Detail:
Type:  Journal Article     Date:  2012-06-20
Journal Detail:
Title:  American heart journal     Volume:  164     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  7-13     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2012 Mosby, Inc. All rights reserved.
The Johns Hopkins Hospital, Baltimore, MD.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): Desi...
Next Document:  CArdiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular ComoRbi...